W G Ryan1, R F Roddam, W E Grizzle
1Department of Psychiatry, University of Alabama School of Medicine, Birmingham.
This study looked at thyroid function in 269 psychiatric patients admitted over two years. They found thyroid disease in 3% and euthyroid abnormalities in 9.3%. Depressed patients had lower T4 and free thyroxine index than those with mania or schizophrenia. The rate of abnormal thyroid tests was lower than in earlier studies. The authors suggest this may be due to changes in lab methods or population differences. They also note that differences in thyroid values by psychiatric diagnosis are new and may need further research.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Prior research has shown that thyroid dysfunction can mimic or exacerbate psychiatric symptoms. However, the frequency and nature of thyroid abnormalities in psychiatric inpatients remain unclear. Earlier studies reported higher rates of thyroid test abnormalities in this population. This gap motivated the current analysis of thyroid function in newly admitted psychiatric patients. The study aimed to clarify whether prior findings were consistent or influenced by other factors. It was already known that thyroid hormones affect mood and cognition, but the extent of this relationship in psychiatric settings was uncertain. No prior work had resolved the discrepancy between earlier reports and potential changes in diagnostic methods. The researchers sought to assess thyroid function in a defined cohort of psychiatric patients. This study contributes to understanding the overlap between endocrine and mental health conditions.
Purpose Of The Study:
The researchers aimed to evaluate thyroid function in newly admitted psychiatric patients over a two-year period. They focused on detecting thyroid disease and euthyroid abnormalities. The motivation stemmed from the need to confirm or challenge earlier findings of high thyroid test abnormalities. They wanted to determine if differences in population or lab techniques explained prior discrepancies. The study also aimed to explore whether specific psychiatric diagnoses correlated with thyroid function. By analyzing T4, T3RU, and free thyroxine index, the team sought to identify patterns. Their goal was to provide updated data for clinical practice in psychiatric settings. This study aimed to inform screening protocols for thyroid function in mental health care.
Thyroid disease was found in 3% of patients, and euthyroid abnormalities in 9.3%.
The researchers measured T4, T3RU, and free thyroxine index.
The authors suggest this may be a new finding worthy of further investigation.
Differences in lab techniques or patient populations may account for the discrepancy.
The study spanned two years and included 269 psychiatric inpatients.
Main Methods:
The researchers conducted thyroid function tests on 269 acute psychiatric patients during admission. They measured T4, T3RU, and free thyroxine index for each participant. The study spanned a two-year period to ensure a representative sample. Patients were diagnosed with depression, mania, or schizophrenia. The team compared thyroid test results across these diagnostic groups. They analyzed the prevalence of thyroid disease and euthyroid abnormalities. Statistical methods were used to assess differences in T4 and free thyroxine index. The study design allowed for comparison with previous psychiatric admission surveys.
Main Results:
Thyroid disease was identified in 3% of the patients, and euthyroid abnormalities occurred in 9.3%. T4 and free thyroxine index were significantly lower in depressed patients. These values were not as low in those with mania or schizophrenia. The overall rate of abnormal thyroid tests was lower than in earlier studies. This difference may be due to changes in lab techniques or population characteristics. The findings suggest a link between depression and lower thyroid function markers. The researchers observed a new pattern in thyroid test results by psychiatric diagnosis. These results may prompt further investigation into the relationship between mood and thyroid function.
Conclusions:
The authors propose that the lower rate of thyroid abnormalities in this study may reflect changes in lab methods or patient populations. They suggest that differences in thyroid function across psychiatric diagnoses are new and warrant further study. The findings do not confirm earlier reports of high thyroid test abnormalities. The researchers emphasize the need for careful interpretation of thyroid function in psychiatric care. They caution against assuming that all psychiatric symptoms are linked to thyroid dysfunction. The study highlights the importance of consistent screening practices in mental health settings. The authors do not claim that thyroid testing is essential for all psychiatric patients. Their results suggest that further research is needed to clarify the relationship between mood and thyroid function.
They propose that differences in thyroid values by diagnosis are new and merit further study.